CCRM Australia
CCRM Australia is the Australian Hub of the highly successful Centre for Commercialization of Regenerative Medicine in Canada (CCRM). Established as a not-for-profit with a national focus, CCRM Australia’s mission is to address bottlenecks in the translation and commercialization of regenerative medicine discoveries in Australia, many of which have the potential to cure some of the most devastating and costly diseases in the world today. CCRM Australia’s commercially focused solutions enable businesses and research partners to achieve their commercialization objectives by providing customized country, market and industry-specific support. To date, CCRM Australia has collaborated with researchers to advance their regenerative medicine technologies, evaluated and supported promising technologies to seek investment funding, facilitated commercialization training and worked with international biotechnology companies to set up their clinical trials in Australia. CCRM Australia continues to do so, while providing access to resources and expertise from other CCRM Hubs around the world.
Posts by: CCRM Australia
Learnings from First Nations’ traditional medicine could enhance the effectiveness of regenerative medicine
This blog post was written by Jimmy Yu (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Traditional medicine and the practices of Australia’s First Nations – Australian Aboriginal people and Torres Strait Islander – embody a world imbued with ancient wisdom, intricate rituals, and spiritual beliefs that have long eluded the grasp of […]
Biotechnology sectors are shaped by different government approaches to investment
This blog post was written by Jimmy Yu (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Countries that responded better during the COVID-19 pandemic showed good, coordinated efforts between different government agencies and departments. Known as the “whole-of-government approach,” this model would help Australia become more self-sustainable in research, manufacturing and commercializing medicine […]
Having the right country alliances is key for internationalization efforts: South Korea
Bhavi Kadakia was an intern with CCRM Australia in 2020 and is currently employed at Novotech. In the health-care sector, translation and commercialization have traditionally been described as complex and requiring heavy investment. As such, it is imperative for biotechnology companies to make the best use of their money and maximize the time to market, […]
Target product profile: Starting that journey of a thousand miles with the right first step
This post is by Harmanpreet Harmanpreet, who interned with CCRM Australia. The CCRM Australia Training Program seeks to facilitate training for the future workforce of the Australian regenerative medicine sector and includes an internship program that accepts undergraduate and postgraduate students from Australia’s universities. Approximately 25 per cent of late-phase clinical trials fail due to […]
CGTs in elite sport: The pinnacle of human evolution or the unnatural demise of fair competition?
This post was written by Tavin Fonseka (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Imagine a world where injuries that once ended careers became nothing more than mere setbacks. Athletes will heal faster, stronger, and with a greater resiliency previously thought impossible. Cell and gene therapies (CGTs)—once reserved for critical medical cases—are […]